Belite Bio, Inc financial data

Symbol
BLTE on Nasdaq
Industry
Pharmaceutical Preparations
Location
12750 High Bluff Drive Suite 475, San Diego, CA
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
20-F - Q4 2023 - Mar 12, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.1M shares +17.1%
Common Stock, Shares, Outstanding 29.1M shares +17.1%
Common Stock, Value, Issued 3K USD 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 88.2M USD +109%
Assets, Current 89.9M USD +110%
Property, Plant and Equipment, Net 490K USD -9.43%
Operating Lease, Right-of-Use Asset 811K USD +0.62%
Assets 94.6M USD +114%
Employee-related Liabilities, Current 727K USD +90.3%
Accrued Liabilities, Current 3.33M USD +74.4%
Liabilities, Current 3.63M USD +72.7%
Operating Lease, Liability, Noncurrent 578K USD -13.5%
Liabilities 4.21M USD +51.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -374K USD +4.59%
Retained Earnings (Accumulated Deficit) -71.5M USD -79.3%
Stockholders' Equity Attributable to Parent 90.4M USD +118%
Liabilities and Equity 94.6M USD +114%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 400M shares -18.7%
Common Stock, Shares, Issued 29.2M shares +17.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 88.2M USD +109%
Deferred Tax Assets, Valuation Allowance 6.22M USD +142%
Deferred Tax Assets, Gross 6.22M USD +142%
Operating Lease, Liability 886K USD +2.31%
Lessee, Operating Lease, Liability, to be Paid 921K USD +1.1%
Operating Lease, Liability, Current 308K USD +55.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 308K USD +32.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 327K USD +50%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35K USD -22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 200K USD -7.41%
Deferred Tax Assets, Operating Loss Carryforwards 5.56M USD +132%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 86K USD -45.6%
Additional Paid in Capital 162M USD +98.5%